ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2022 American Transplant Congress

    Surveillance with Protocol Biopsies for Rejection Significantly Impacts Survival Following Intestine Transplant

    J. R. Sherwood1, Y. Ichkhanian2, N. Beltran3, S. Nagai3, S. Jafri4

    1Wayne State School of Medicine, Detroit, MI, 2Department of Internal Medicine, Henry Ford Hospital, Detroit, MI, 3Department of Transplant Surgery, Henry Ford Hospital, Detroit, MI, 4Division of Gastroenterology and Hepatology, Henry Ford Hospital, Detroit, MI

    *Purpose: Frequent surveillance biopsy is required on the first month post intestinal transplant(IT) due to high-risk of acute rejection. However, the utility and the frequency…
  • 2022 American Transplant Congress

    Novel Portable Hypothermic Cardiac Preservation Device Enhances Cardiac Viability and Function of the Isolated Porcine Hearts

    K. Andrijauskaite, R. J. Veraza, R. P. Lopez, E. C. Cisneros, I. J. Jessop, M. D. Watt, L. Bunegin

    Vascular Perfusion Solutions, Inc, San Antonio, TX

    *Purpose: Cardiac heart transplantation is the gold standard for treating end-stage heart failure; however, the list of patients waiting for heart transplants continues to increase.…
  • 2022 American Transplant Congress

    Characterization of Kidney Allograft Pathology Using the Histomap Gene Expression Profile (GEP) and Formalin Fixed Paraffin Embedded (FFPE) Tissue

    N. Garg1, K. Degner2, H. Zhang3, W. Tian3, F. Aziz4, S. Parajuli2, W. Zhong2, N. Wilson2, S. Panzer1, A. Djamali2

    1University of Wisconsin Madison, Madison, WI, 2University of Wisconsin, Madison, WI, 3CareDx, Brisbane, CA, 4University of Wsiconsin, Madison, WI

    *Purpose: The new Banff Human Organ Transplant (B-HOT) gene panel assessed on nCounter system has been created through a collaboration between NanoString and the Banff…
  • 2022 American Transplant Congress

    Chronic Active Antibody Mediated Rejection: 3 Month Response Rates to Treatment and Predictors of Graft Survival

    F. Aziz, M. Jorgenson, S. Parajuli, N. Garg, V. Manchala, E. Yousif, D. Mandelbrot, L. Hidalgo, M. Mohamed, W. Zhong, A. Djamali

    University of Wisconsin, Madison, WI

    *Purpose: There is limited information on effectiveness of treatment and predictors of graft survival following chronic active antibody mediated rejection (cABMR) in kidney transplant recipients…
  • 2022 American Transplant Congress

    Implementing Genetic Testing in the Evaluation of the Kidney Transplant Candidate

    F. Abu Al Rub1, Y. Caliskan2, H. Randall2, B. Bastani2, V. Fleetwood3, M. Nazzal2, C. Varma2, K. Lentine2

    1St. Louis University, St Louis, MO, 2St. Louis University, St. Louis, MO, 3Department of Transplantation, St. Louis University, St. Louis, MO

    *Purpose: To describe the incorporation of a genetic renal panel to improve the characterization of end stage kidney disease (ESKD) etiology in the kidney transplant…
  • 2022 American Transplant Congress

    Measurement of Physical Activity and Frailty in the Early Post-Operative Period After Kidney Transplant-Single-Center Prospective Pilot Study Using Fitbit Watch

    T. Shamaa, L. Allenspach, O. Shamaa, S. Shimada, C. Crombez, O. Hage-Hassan, T. Kitajima, S. Yeddula, I. Bajjoka, L. Malinzak, J. Denny, D. Kim, M. Abouljoud, S. Nagai

    Henry Ford Transplant Institute, Detroit, MI

    *Purpose: Physical activity monitors (PAMs) allow patients to track multiple health parameters. PAM’s may be helpful to assess a patient’s physical recovery after a Kidney…
  • 2022 American Transplant Congress

    Mitochondrial Transplant as Novel Therapeutic Modality to Reduce Nonalcoholic Fatty Liver Disease

    M. Namwanje1, A. Stayton1, C. White1, C. Kuscu1, C. Kuscu1, J. Eason2, A. Bajwa1

    1Transplant Research Institute, James D. Eason Transplant Institute, Department of Surgery, The University of Tennessee Health Science Center, Memphis, TN, 2University of Tennessee/Methodist Transplant Institute, Memphis, TN

    *Purpose: Mitochondrial dysfunction in adipose tissue is one of the mechanisms contributing to obesity and its co-morbidities. Transfer of healthy mitochondria has proven successful in…
  • 2022 American Transplant Congress

    Neutrophil CEACAM1 Regulates Extracellular Trap Formation via Non-Canonical Inflammasome Signaling and Impacts Liver Transplantation in Mouse and Human

    H. Hirao, H. Kojima, K. Kadono, K. J. Dery, D. G. Farmer, F. M. Kaldas, J. Kupiec-Weglinski

    UCLA, Los Angeles, CA

    *Purpose: Neutrophil extracellular trap (NET) formation relates to various diseases, including sterile inflammation. Although neutrophils express proficient CEACAM1 (CC1, also known as CD66a) long isoform,…
  • 2022 American Transplant Congress

    Lung Transplant Waitlist Outcomes for Blood Group O Candidates After the Expansion of the Primary Allocation Unit in November 2017

    S. Greissman1, M. Anderson2, S. Arcasoy3, A. Dimango3, M. Gabriela3, H. Grewal3, H. Robbins3, L. Shah3, J. Costa3, F. D'Ovidio3, M. Leiva Juarez3, P. Lemaitre3, J. Sonett3, L. Benvenuto3

    1Department of Internal Medicine, New York Presbyterian, New York, NY, 2University of Pennsylvania, Philadelphia, PA, 3Columbia University, New York, NY

    *Purpose: Blood group O is associated with decreased lung transplant rates. Occasionally, blood group donor O lungs are allocated to non-blood group O recipients. Since…
  • 2022 American Transplant Congress

    Broad Panel Genetic Testing for Chronic Kidney Disease in the Transplant Center

    A. Bhalla1, D. Raible2, V. Balaraman1, M. Talwar1

    1James D. Eason Transplant Institute, Methodist University Hospital, Memphis, TN, 2Natera, Inc., Austin, TX

    *Purpose: Genetic testing is an emerging tool for ‌the evaluation of patients with end-stage renal disease (ESRD). In kidney transplantation (KT), testing can identify disease…
  • « Previous Page
  • 1
  • …
  • 54
  • 55
  • 56
  • 57
  • 58
  • …
  • 190
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences